Clinical Trials Logo

Deafness clinical trials

View clinical trials related to Deafness.

Filter by:

NCT ID: NCT05343026 Not yet recruiting - Clinical trials for Tinnitus, Subjective

Efficacy of Hearing-aid Treatment for Patients With Tinnitus and Co-existing Hearing Loss

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Considering the extent to which HAs play a role in sound perception and residual hearing preservation among patients with tinnitus and co-existing HL remains a lack of compelling extensive evidence, investigators designed this single-blind, 6-months randomized, controlled trial with two parallel groups. One is the HA treatment group, and the other is the waiting list control (WLC) group which receives no interventions during this period.

NCT ID: NCT05329207 Not yet recruiting - Health Promotion Clinical Trials

Effects of Web-Based Adolescent Health Promotion Program in Hearing Impaired Adolescents

ASGE-FABES
Start date: April 18, 2022
Phase: N/A
Study type: Interventional

Our research is to evaluate the effect and applicability of the adolescent health promotion program, which includes multiple behavioral interventions, on physical activity, nutrition and mental health of hearing impaired adolescents living in the community.

NCT ID: NCT05154188 Not yet recruiting - Clinical trials for Sensorineural Hearing Loss, Bilateral

Post Approval Study to Assure the ContInued saFety and effectIveness of Neuro Cochlear Implant System in Adult Users

PACIFIC
Start date: September 1, 2025
Phase:
Study type: Observational

On June 23, 2021, the Oticon Medical Neuro Cochlear Implant System (NCIS) was granted premarket approval (PMA) in the US to treat individuals 18 years or older, with bilateral severe-to-profound sensorineural hearing loss, who obtain limited benefit from appropriately fitted hearing aid(s). To help assure the continued safety and effectiveness of an approved device, a post-approval study was required as a condition of approval under 21 CFR 814.82(a)(2). The purpose of this study is to provide longer-term data on the safety and effectiveness of the Neuro Cochlear Implant System under general conditions of use in the postmarket environment.

NCT ID: NCT05152589 Not yet recruiting - Hearing Loss Clinical Trials

Maternal Diabetes in Newborns With Hearing Loss

GDM
Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

This study aims to investigate the presence and characteristics of maternal diabetes as a risk factor in newborns with hearing loss. Hearing loss is one of the most common congenital anomalies among newborns. The newborn hearing screening program is important for early diagnosis in newborns with hearing loss.Gestational diabetes, on the other hand, is a metabolic disease that occurs during pregnancy and can cause complications as in other diabetes mellitus patients. Despite our knowledge of major complications, the effect of the hyperglycemic intrauterine environment on hearing outcomes has not been adequately studied. The inner ear does not store energy, so it has a particularly high sensitivity to altered blood sugar and insulin. Altered inner ear metabolism leads to auditory and balance disorders. There is no study in the literature comparing uncomplicated gestational diabetes and pregestational diabetes as a prenatal complication that poses a risk of hearing loss.

NCT ID: NCT04427631 Not yet recruiting - Clinical trials for Hearing Loss, Conductive

Exploring Interventions for Glue Ear During Covid-19

BIG-C
Start date: June 22, 2020
Phase: N/A
Study type: Interventional

During the Coronavirus pandemic children's hearing services are closed or reduced and grommet operations are part of the lowest priority group. In the absence of management options, this research study aims to see if bone conduction headphones either paired (via bluetooth) to a microphone or an app will help children with a hearing loss during this period of waiting. The child's quality of life is measured with validated questionnaires The study is over 3 months, and delivered remotely, with the product being sent to the family home and support offered via telephone/ video consulattion.

NCT ID: NCT04350619 Not yet recruiting - Congenital Deafness Clinical Trials

NGS Assessment of Congenitally Deafned Children and Neonatal Deafness Screnning

GHELP
Start date: April 30, 2020
Phase:
Study type: Observational

To assess the diagnostic value of NGS screnning in prelingually deafned children using a new designed chip, and to evaluate its interest in a the neonatal screening program for ddetecting congenitally deafned children.

NCT ID: NCT04283279 Not yet recruiting - Hearing Loss Clinical Trials

Exercise to Improve Balance in Older Adults With Hearing Impairment - a Proof-of-concept Study

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Hearing impairment is common in older adults, and recent research points to associations between hearing impairment and balance/mobility. The association may be due to more attentional resources being used to compensate for the sensory loss, with less resources available for maintaining balance. The aim of this projects is therefore to investigate whether an exercise program with focus on motor-cognitive tasks is feasible for older adults with hearing impairment. The study is meant as a proof-of-concept study, where trialling will be evaluated, and results will be used to inform the design of a larger and adequately powered study.

NCT ID: NCT04224909 Not yet recruiting - Clinical trials for Sudden Sensorineural Hearing Loss

Video HIT in Sudden Sensorineural Hearing Loss

Start date: February 1, 2020
Phase:
Study type: Observational

The function of the vestibular system among patients with Sudden Sensori Neural Hearing Loss will be evaluted using the video Head Impulse Test

NCT ID: NCT04155138 Not yet recruiting - Cochlear Implant Clinical Trials

Recipients With Limited Bimodal Benefit: HA or CROS

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

The rationale is to determine (in individuals with limited perceived bimodal benefit) whether the CROS device may be a better solution for obtaining two-sided input. If yes, this study would be practice-changing.

NCT ID: NCT04129983 Not yet recruiting - Clinical trials for Hearing Loss, Sudden

Treatment of Sudden Deafness With Prednisone+Hyperbaric Oxygen and Prednisone+Somatosensory Stimulation

Start date: June 2020
Phase: N/A
Study type: Interventional

To study the effective treatment of sudden deafness by giving prednisone, hyperbaric oxygen and somatosensory stimulation to sudden deafness patients.